GUIDELINES FOR AUTHORS

Online manuscript submission

International Diabetes Nursing is published at www.FENDjournal.org. The process takes place online from submission to publication. Authors must first register online with the journal website at: http://www.fendjournal.org/index.php/idn/information/authors, and then login as an author. Email confirmation will be sent automatically. Authors are then guided through the submission process.

Submission verification and research misconduct

Submitted manuscripts must be original and not previously published in any form in English or any other language (except in the form of an abstract). Furthermore, articles must not be under consideration for publication elsewhere. Manuscripts under review by this journal should not be resubmitted to other copyrighted publications. Articles are considered approved by all authors and tacitly or explicitly by the responsible authorities where the research was carried out.

International Diabetes Nursing considers as unacceptable research misconduct such as falsification or fabrication of data, omitted information about data, plagiarism or not clearly declared conflict of interest. To verify originality the manuscript may be checked by plagiarism software.

Types of articles

International Diabetes Nursing considers the following article types for publication:

  • Research Articles: articles that report results of a study (quantitative, qualitative, or mixed methods) carried out within the diabetes nursing context or of general interest for diabetes nursing care.
  • Reviews: short reviews, scoping reviews, literature reviews, integrative reviews, systematic reviews, meta-analyses, meta-syntheses, overview, and umbrella reviews. 
  • Methodological Articles: discussions on the development and/or application of tools or methodologies within different nursing settings useful for diabetes care.
  • Research Protocols: protocols which describe the development of a study already approved by an ethics committee.
  • Case Reports: analysis or discussion of a diabetes nursing case which is of interest as a starting point for future research and/or discussion.
  • Professional and Policy Articles: discussions of professional development, policy issues, philosophical, theoretical, or organisational models, best practice experience, and hot topic debates, within the field of diabetes nursing and diabetes care.

Where available the EQUATOR (Equator Network - Enhancing the QUAlity and Transparency Of health Research) Guidelines for the appropriate study design should be followed by authors (https://www.equator-network.org/).

Authors' responsibilities

  • Authors of original papers must present an accurate description of the work performed as well as an objective discussion of its significance.
  • Underlying data must be represented accurately in the paper which should contain details and references to permit others to replicate the work.
  • Fraudulent, or knowingly inaccurate, statements constitute unethical behaviour and are unacceptable. Authors may be asked to provide the raw data of their study together with the paper for editorial review and should be prepared to make the data publicly available.
  • Authors must submit only entirely original work and will appropriately cite or quote the work of others.
  • Authorship is limited to those who have made a significant contribution according to authorship criteria (see section below).
  • All authors should include a statement disclosing any conflicts of interest that may be construed to influence the results of their work. All sources of financial support for the project should be disclosed.

Authorship criteria

According to the International Committee of Medical Journal Editors, authorship is based on the following four criteria:

  1. substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work
  2. drafting the work or revising it critically for important intellectual content
  3. AND final approval of the version to be published.
  4. agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
  • Designated authors should meet all four criteria for authorship and all who meet the criteria should be identified as authors. The senior author is responsible for identifying who meets the criteria.
  • The corresponding author is the individual who takes primary responsibility for communication with the journal during manuscript submission, peer review, and publication process. They typically ensure that administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation (where applicable), and gathering conflict of interest forms and statements, are properly completed.
  • The corresponding author should be available throughout the submission and peer review process to respond to editorial queries in a timely way and should be available after publication to respond to critiques of the work and cooperate with any requests that may arise after publication.
  • Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship. For more information about authorship criteria please refer to The International Committee of Medical Journal Editors (ICMJE) http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html.

Acknowledgements should be as brief as possible. Contributions from anyone who does not meet criteria for authorship should be listed, along with editorial assistance, with permission from the contributor. Financial and material support should also be acknowledged.

Reporting and ethical guidelines

International Diabetes Nursing strives for the highest ethical standards in editorial and publishing conduct. The publication ethics and publication malpractice statement is based on the Core Practices (Committee on Publication Ethics, 2017, https://publicationethics.org/core-practices) and agrees with the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals (International Committee of Medical Journal Editors, 2019, http://www.icmje.org) and the Publication Manual of the American Psychological Association (seventh edition, 2020, https://apastyle.apa.org). Furthermore, International Diabetes Nursing fully adheres to the  EQUATOR Network for the best reporting of scientific results http://www.equator-network.org. 

Studies described must be carried out in accordance with the Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects (World Medical Association, https://www.wma.net). Studies on patients or volunteers require ethics committee approval and informed consent. The approving body and (if applicable) approval number should be identified. Appropriate consents, permissions and releases must be obtained where authors wish to include case details, other personal information, or images of patients and any other individuals. Written consent must be retained by authors and copies of the consent or evidence that such consent has been obtained must be provided on request.

Organisation and content of papers

1. Title page: title of the paper, authors names, affiliation, corresponding author, type of article (e.g., Research Article, Review). The title should be no more than two typeset lines and should be comprehensible to an international scientific audience.

For each author affiliation include the highest academic title, role, department, and institution. The corresponding author must indicate name, affiliation, complete address, telephone number, and email address. This information will appear in the article footnotes.

It must be clearly stated in this file that the manuscript is original, is not submitted for publication elsewhere, the contribution of each author, disclosure of conflicts of interest.

Please state the total word count for the body of the manuscript, as detailed below.

2. Manuscript main document file: that must be treated as a blind document by the authors. This file must include the following elements.

a) Abstract (max 350 words). Where applicable, the abstract should be structured and submitted following the IMRaD (introduction, methods, results, and discussion) format.

b) Keywords (max 6). Abstracts should be followed by a maximum of 6 key words preferably expressed as MeSH (Medical Subject Headings, https://www.nlm.nih.gov/mesh/) terms.

c) Manuscript (max 6000 words). All manuscripts must be written in UK English, Oxford English Dictionary, -ise ending and submitted in Word MS format, Times New Roman with a font size 12, and should be follow a common format, as the article is developed. Manuscripts must be no more than 6000 words in length (excluding abstract, references and tables). Editors will approve exceptions on a case-by-case basis.

d) Tables, graphs, figures (a maximum of 6 tables/graphs per article) should be included in the main document file. Tables should contain only essential data and each figure should have a legend numbered in Arabic numerals. If all or part of previously published illustrations are used, permission must be obtained from the copyright holder. No supplementary tables or graphs are admitted.

e) References should be included in the main document file. International Diabetes Nursing follows the Vancouver style, i.e., numbered sequentially in superscript as they occur in the text, and ordered numerically in the reference list.

  • All citations mentioned in the text, tables or figures must be listed in the reference list.
  • If cited in tables or figure legends, number according to first mention of table or figure in the text.
  • Reference to ‘unpublished data, personal communication, in preparation, submitted for publication’, should not appear in the reference list but incorporated in parentheses in the text. Written consent for publication must be provided. (e.g., Brown B, 2014, unpublished data)
  • Papers quoted as ‘in press’. Authors should provide an electronic version of manuscripts cited as ‘in press’ when they submit their manuscript. If an accepted paper contains references to a manuscript in press, written evidence that the manuscript has been accepted will be requested.
  • Authors are responsible for the accuracy of the references.

Examples of references content requirements

It is important that all key elements of each reference are included. Please see below for examples of reference content requirements:

Journal Article Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 30:219–225

Online Article Not Yet Published in an Issue [An online article that has not yet been published in an issue (therefore no volume, issue or page numbers) can be cited by its Digital Object Identifier (DOI). The DOI stays valid and allows an article to be tracked even after its allocation to an issue.] DC Diriba, DYP Leung, LKP Suen. A nurse-led, community-based self-management program for people living with type 2 diabetes in Western Ethiopia: a feasibility and pilot study protocol. Diabetic Medicine 2021. https://doi.org/10.1111/dme.14587

Whole book Kaufmann HE, Baron BA, McDonald MB, Waltman SR (eds) The cornea, 2nd edn. New York: Churchill Livingstone, 1998

Chapter in a Book Hopper JL. Why ‘common environmental effects’ are so uncommon in the literature. In: Spector TD, Snieder H, MacGregor AJ (eds) Advances in twin and sib-pair analysis. London, Oxford University Press, 2000; 151-165

Electronic Material www.FEND.org (homepage on internet). Foundation of European Nurses in Diabetes. Aims of the ENDCUP Programme. (Accessed 20 April 2021) Available from: https://www.fend.org/projects/fend-endcup/aims-programme

Authors should be aware that articles with the wrong referencing style will not be considered for publication.

Style guide

  • The term 'diabetic' should not be used as a noun. Preferred style is ‘people (or person or individual) with diabetes’ or ‘in the group without diabetes’, rather than ‘diabetic people (or person)’, 'diabetic patient' or ‘non-diabetic group’.
  • The terms 'Type 1' and 'Type 2 diabetes mellitus' should be used rather than IDDM and NIDDM. Diabetes should not be abbreviated to DM but it is acceptable to omit mellitus.
  • 'Men' and 'women' should be used in preference to 'males' and 'females'. ‘Participant(s)’ or ‘person’/’people’ is preferred to ‘patient(s)’ or ‘subject(s)’ to reflect the collaborative nature of modern clinical research.

 Abbreviations and Units

  • Abbreviations are strongly discouraged except for units of measurement. Non-standard abbreviations should not be used. Avoid abbreviations in the title of the manuscript and in the abstract. At first mention the abbreviation should be spelled-out in full followed by the abbreviation in parentheses unless it is a standard unit of measurement.
  • SI units must be used throughout except for blood pressure (mmHg) and haemoglobin (g/l). Gas or pressure values should be given as mmHg with kPa in parentheses or vice versa.
  • Where molecular weight is known, the amount of a substance should be expressed in mol or appropriate subunit (mmol). Energy should be expressed in kcal or joules (J).
  • The solidus may be used in a unit only if it is not used more than once (e.g. mmol/l is acceptable), but ml/min/kg is not acceptable and should be replaced with ml min-1 kg-1.

 HbA1c Measurement

  • Results for HbA1cshould be presented in mmol/mol with percentage units in parentheses, e.g., HbA1c was 31 mmol/mol (5.0%).
  • In tables please include HbA1cvalues expressed in mmol/mol in a separate row above % values.
  • Except for regression analyses (where units should be reported in mmol/mol), please dual report HbA1cvalues for all analyses.
  • HbA1cvalues should be presented in mmol/mol in figures. If referring to previously reported results (e.g., in the Discussion section of your paper), please use mmol/mol.

Proofs

Corresponding authors will receive an email message with the article proof for correction and verification. International Diabetes Nursing will do everything possible to get articles published quickly and accurately. At this stage authors should check typesetting, editing, text, tables and figures for completeness and correctness. Significant changes to the article as accepted for publication will only be considered at this stage where allowed by the Editors. All corrections should be sent back in one single communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed.

Neither the editors nor the associate editors are responsible for authors’ expressed opinions, views, and the contents of the published manuscripts in the journal. The originality, proofreading of manuscripts and errors are the sole responsibility of the individual authors. In the case of language issues, the editors require the authors refer to a professional editing services that is chosen by the authors. Following that, the authors may be asked to prove with certificate or email that professional editing was carried out.

Permissions

Figures and/or tables taken from previous publications must be accompanied by either a statement (e.g., from RightsLink, http://www.copyright.com/publishers/rightslink/) giving permission to International Diabetes Nursing for reproduction in print and electronic formats, or details of the Creative Commons Attribution (CC BY) licence, which permits sharing and adaptation of another’s work providing the original source is properly cited.  Note that permission is usually required for publication of an adapted figure/table. It is the responsibility of the submitting author to investigate whether permission is needed and to pay any fees associated with obtaining permission.